drugset / Trial / NCT02903108

Clinical Efficacy of 0.75% Boric Acid Gel in Chronic Periodontitis

NCT02903108

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the present study was to evaluate the effects of subgingival delivery of boric acid gel as an adjunct to scaling and root planing in chronic periodontitis (CP) patients.

Timeline

Start
2015-05
Primary completion
2015-10
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Boric acid Small molecule 0.75 % Other

Indications